Integrated Wealth Concepts LLC

Position in ABOS — Acumen Pharmaceuticals, Inc.

CIK 1737109 WALTHAM, MA

Position in ABOS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$27,177

+$3,155 QoQ

Shares Held

10,179

0.0% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 96 holders

Holding Since

Sep 2023

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Integrated Wealth Concepts LLC holds $51,111,337 across 302 Biotechnology names. ABOS ranks #108 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMRN	Biomarin Pharmaceutical Inc	152,216	$8,709,799
2	INVA	Innoviva, Inc.	350,575	$7,961,558
3	EXEL	Exelixis, Inc.	69,926	$3,804,673
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6,994	$3,474,129
5	DNLI	Denali Therapeutics Inc.	102,241	$2,629,638
6	ALNY	Alnylam Pharmaceuticals, Inc.	6,692	$2,014,492
7	INCY	Incyte Corp	17,318	$1,963,168
8	TLX	Telix Pharmaceuticals Ltd	164,397	$1,895,497

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,177	10,179	0.0%	Shares	Sole	2026-08-12
2026-03-31	$24,022	10,179	0.0%	Shares	Sole	2026-05-15
2025-09-30	$17,406	10,179	-2.4%	Shares	Sole	2025-11-14
2025-06-30	$12,094	10,426	-31.5%	Shares	Sole	2025-08-14
2025-03-31	$16,740	15,219	+50.7%	Shares	Sole	2025-05-15
2024-12-31	$17,372	10,100	0.0%	Shares	Sole	2025-02-14
2024-03-31	$40,905	10,100	-30.8%	Shares	Sole	2024-05-15
2023-12-31	$56,064	14,600	+7.4%	Shares	Sole	2024-02-13
2023-09-30	$56,440	13,600	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.